Product Description
Mechanisms of Action: HO1 Inducer
Novel Mechanism: Yes
Modality: Small Molecule
Route of Administration: Oral
FDA Designation: *
Approval Status: Not Approved
Approved Countries: Australia | China | Korea
Approved Indications: None
Known Adverse Events: None
Company: ZERIA
Company Location:
Company CEO:
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Phase 3: Taste Disorders
Phase 2: Prostate Cancer|Intestinal Diseases|Lymphoma|Leukemia|Colorectal Cancer|Liver Cancer|Digestive System Cancer|Mucositis|Gastrointestinal Cancer|Mouth Cancer
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|
| CTR20251497 | N/A |
Completed |
Healthy Volunteers |
2025-06-02 |
2025-06-29 |
Patient Enrollment|Primary Completion Date|Start Date|Study Completion Date|Treatments|Trial Status |
|
| GER | N/A |
Not yet recruiting |
Esophagitis, Peptic|Gastroesophageal Reflux |
2025-04-01 |
2024-11-08 |
Primary Endpoints|Treatments |
|
| CTR20250777 | N/A |
Completed |
Healthy Volunteers |
2025-03-23 |
2025-04-29 |
Patient Enrollment|Primary Completion Date|Start Date|Study Completion Date|Treatments|Trial Status |
|
| CTR20244758 | N/A |
Completed |
Healthy Volunteers |
2025-01-16 |
2025-04-29 |
Patient Enrollment|Primary Completion Date|Start Date|Study Completion Date|Treatments|Trial Status |
|
| CTR20243088 | N/A |
Completed |
Healthy Volunteers |
2024-12-07 |
2025-04-29 |
Patient Enrollment|Primary Completion Date|Start Date|Study Completion Date|Treatments|Trial Status |
|
| CTR20242711 | N/A |
Completed |
Healthy Volunteers |
2024-11-14 |
2025-04-29 |
Patient Enrollment|Primary Completion Date|Start Date|Study Completion Date|Treatments|Trial Status |
|
| ChiCTR2300070469 | N/A |
Not yet recruiting |
Helicobacter Infections |
2024-02-29 |
2023-06-09 |
Treatments |
|
| ChiCTR1900028329 | N/A |
Recruiting |
Unknown |
2022-12-31 |
|||
| CTR20210011 | N/A |
Completed |
Healthy Volunteers |
2021-01-13 |
2025-04-29 |
Patient Enrollment|Primary Completion Date|Study Completion Date|Treatments|Trial Status |
|
| CTR20202184 | N/A |
Completed |
Healthy Volunteers |
2020-12-19 |
2025-04-29 |
Treatments |
|
| ChiCTR1900025800 | N/A |
Not yet recruiting |
Helicobacter Infections |
2020-03-15 |
|||
| NCT02243618 | N/A |
Completed |
Adenoma|Gastrointestinal Cancer |
2016-04-14 |
2019-03-28 |
Patient Enrollment|Primary Completion Date|Start Date|Study Completion Date|Treatments|Trial Status |
|
| ChiCTR-IIR-16009688 | N/A |
Completed |
Helicobacter Infections|Gastritis |
2015-06-30 |
|||
| JapicCTI-111633 | N/A |
Completed |
Other |
2007-08-01 |
|||
| JapicCTI-050077 | N/A |
Unknown |
Helicobacter Infections |
2006-12-01 |
|||
| CTR20244559 | N/A |
Not yet recruiting |
Healthy Volunteers |
None |
2025-04-29 |
Patient Enrollment|Treatments|Trial Status |
|
| CTR20244281 | N/A |
Not yet recruiting |
Healthy Volunteers |
None |
2025-04-29 |
Patient Enrollment|Treatments|Trial Status |
|
| CTR20243117 | N/A |
Not yet recruiting |
Healthy Volunteers |
None |
2025-04-29 |
Treatments|Trial Status |
|
| CTR20232872 | N/A |
Not yet recruiting |
Healthy Volunteers |
None |
2025-04-29 |
Patient Enrollment|Treatments|Trial Status |
|
| PEACe | P2 |
Completed |
Prostate Cancer |
2023-01-20 |
2023-07-12 |
Patient Enrollment|Primary Completion Date|Primary Endpoints|Study Completion Date|Treatments|Trial Status |
|
| ToPaZ Study | P2 |
Completed |
Lymphoma|Liver Cancer|Intestinal Diseases|Digestive System Cancer|Mucositis|Leukemia|Colorectal Cancer|Gastrointestinal Cancer|Mouth Cancer |
2022-07-01 |
2025-06-26 |
Treatments |
|
| JapicCTI-121907 | P3 |
Completed |
Taste Disorders |
2014-09-30 |